A cancer startup just raised millions from a pharmaceutical giant, and it could be where the industry is headed
YouTube and LinkedIn
YouTube and LinkedIn
View all Offers
- 30% OFF
Duroflex LiveIn - Pressure Relieving, Memory Foam, Roll Pack, 8 Inch King Size Medium Firm Mattress with Superior Comfort and Anti Microbial Fabric (78 X 72 X 8 Inches)₹ 13819₹ 21999Buy On
- 4% OFF
Duroflex Back Magic - Doctor Recommended Orthopaedic High Density Coir, 5 Inch Queen Size Firm Mattress for Back Support and Posture Alignment (75 X 60 X 5 Inches)₹ 16909₹ 20008Buy On
- 21% OFF
MBTC Xcelo Mesh Office Chair (Black)₹ 3399₹ 4999Buy On
- 33% OFF
Duroflex LiveIn - Pressure Relieving, Memory Foam, Roll Pack, 6 Inch Double Size Medium Firm Mattress with Superior Comfort and Anti Microbial Fabric (72 X 48 X 6 Inches)₹ 9059₹ 14999Buy On
Amazon Brand - Solimo Medusa Engineered Wood Wardrobe with Mirror Wenge , 2 Doors₹ 8809₹ 15000Buy On
That could be the sign of bigger things to come.
While cloud-based cancer software startup Flatiron Health raised $175 million in its latest funding round, led by drug company Roche, tech and health collaborations have been abounding elsewhere as well.
Aging, disease, and robots
In 2014, biopharmaceutical company AbbVie partnered with Google (now Alphabet) and founded Calico to researchers age-related diseases. Late last year, Alphabet's newly renamed Verily recently partnered with Johnson and Johnson to make smaller, cheaper robots. And in January 2015, Genentech (which is owned by Roche) made a $60-million partnership with genetic testing company 23andMe to study Parkinson's.
Also last year, Roche struck a deal with biotech company Foundation Health at $1.03 billion, giving Roche a majority stake in the company that was also backed by Google and Bill Gates. Foundation Health runs genetic tests to determine the best cancer treatment for patients.
How drug companies might use these partnerships to their advantage
A quick scan of Roche's pipeline shows 34 drugs in development that have never been approved (also known as new molecular entities). Flatiron Health's software analyzes cancer treatment results, which can help health care providers who subscribe to the service find the best ways to attack the disease. Flatiron Health said in a release that it will work with Roche to speed up clinical trials for new cancer treatments.
- Amazon Great Republic Day Sale — Best deals and offers on Apple iPhones, iPads, and more
- ‘Extreme fear’ is ruling the crypto markets — is this an opportunity or a warning sign for investors?
- El Salvador's president hits back on Twitter after rating agency Moody's issues warning over its bitcoin buying
- Best deals on hair straighteners, trimmers and other grooming products on Amazon
- Amazon Republic Day Sale 2022 — Best deals and offers on Echo smart speakers, Fire TV Sticks and more
- Two IndiGo planes avert mid-air collision over Bengaluru airport, DGCA to take strict action
- India's tennis star Sania Mirza announces retirement from the sport by the end of 2022 season
- EaseMyTrip launches a new campaign featuring Vijay Raaz and Varun Sharma to promote its full-refund medical policy